This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Astrazeneca Ab. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Angela Charlotte Currie: Innovator in mTOR Kinase Inhibitors
Introduction
Angela Charlotte Currie is a notable inventor based in Macclesfield, GB. She has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds that target specific biological pathways.
Latest Patents
Angela holds a patent for a process related to the preparation of novel pyridopyrazines as mTOR kinase inhibitors. This patent outlines a method for synthesizing a compound of Formula 1, which can be utilized in the preparation of various salts, including fumarate salts, for therapeutic applications.
Career Highlights
Angela is currently employed at AstraZeneca, a leading global biopharmaceutical company. Her work focuses on innovative drug development, contributing to advancements in therapies that address critical health issues.
Collaborations
Angela has collaborated with esteemed colleagues, including Helen Blade and Gwydion Huw Churchill, enhancing the research and development efforts within her team.
Conclusion
Angela Charlotte Currie's work exemplifies the impact of innovative research in the pharmaceutical industry. Her contributions to mTOR kinase inhibitors highlight the importance of continued exploration in medicinal chemistry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile